Tag #Pharmaceutical Investment

What are the immediate consequences of AstraZeneca's decision to cancel the Merseyside vaccine plant expansion?

AstraZeneca cancelled a £450 million expansion of its Merseyside vaccine plant, disappointing the UK science minister. The company cited a reduced government offer compared to a previous proposal, resulting in a smaller planned UK research and development investment. This decision impacts UK research and development and jobs.